Harlan W. Waksal

机构：Eon Corporation (United States)

发表论文 30 篇 · 总被引 3286 次 · h-index 16

代表论文

• Phase I Studies of Anti–Epidermal Growth Factor Receptor Chimeric Antibody C225 Alone and in Combination With Cisplatin (2000 · Journal of Clinical Oncology · 被引 747)
• Phase I Study of Anti–Epidermal Growth Factor Receptor Antibody Cetuximab in Combination With Radiation Therapy in Patients With Advanced Head and Neck Cancer (2001 · Journal of Clinical Oncology · 被引 475)
• Enhanced antitumor activity of anti-epidermal growth factor receptor monoclonal antibody IMC-C225 in combination with irinotecan (CPT-11) against human colorectal tumor xenografts. (2002 · PubMed · 被引 354)
• Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study (2021 · Blood · 被引 353)
• Epidermal growth factor receptor-targeted therapy with C225 and cisplatin in patients with head and neck cancer. (2001 · PubMed · 被引 299)
• Enhanced apoptosis with combination C225/radiation treatment serves as the impetus for clinical investigation in head and neck cancers. (2000 · PubMed · 被引 220)